GlobeNewswire: KBL MERGER CORP. IV Contains the last 10 of 4 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T13:44:18ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/11/09/2122737/0/en/KBL-Merger-Corp-IV-Announces-Completion-of-Acquisition-of-180-Life-Sciences-Corp-and-Trading-Under-the-ticker-ATNF-Starting-November-9-2020.html?f=22&fvtc=4&fvtv=62034KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 20202020-11-09T13:00:00Z<![CDATA[NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC), today announced the successful completion of its acquisition of 180 Life Sciences Corp. ("180 Life Sciences"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain.]]>https://www.globenewswire.com/news-release/2020/11/06/2122186/0/en/KBL-Merger-Corp-IV-Announces-Approval-of-Business-Combination-with-180-Life-Sciences-at-the-Special-Meeting-of-Shareholders-Held-on-November-5-2020.html?f=22&fvtc=4&fvtv=62034KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 20202020-11-06T20:07:22Z<![CDATA[NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180 Life Sciences Corp. ("180 Life Sciences"), today announced that a special meeting (the “Meeting”) of the stockholders of KBL Merger Corp. IV (the “Company”) was held on November 5, 2020, where all proposals, including the proposal to approve the proposed business combination with 180 Life Sciences, were approved.]]>https://www.globenewswire.com/news-release/2020/10/23/2113646/0/en/KBL-Merger-Corp-IV-Announces-Change-of-Special-Meeting-of-Shareholders-Date-to-November-5-2020.html?f=22&fvtc=4&fvtv=62034KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 20202020-10-23T12:30:00Z<![CDATA[NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180 Life Sciences Corp. ("180 Life Sciences"), today announced that the special meeting of its stockholders (the “Special Meeting”) originally scheduled for Monday, October 26, 2020, is being postponed to November 5, 2020.]]>https://www.globenewswire.com/news-release/2020/10/12/2106884/0/en/KBL-Merger-Corp-IV-Announces-Special-Meeting-of-Shareholders-to-be-Held-October-26-2020-upon-the-SEC-Declaring-the-S-4-Registration-Statement-Effective.html?f=22&fvtc=4&fvtv=62034KBL Merger Corp. IV Announces Special Meeting of Shareholders to be Held October 26, 2020 upon the SEC Declaring the S-4 Registration Statement Effective2020-10-12T13:30:00Z<![CDATA[S-4 Declared Effective, Proxy Statement Mailed to Stockholders of Record as of Close of Business on September 30, 2020 S-4 Declared Effective, Proxy Statement Mailed to Stockholders of Record as of Close of Business on September 30, 2020]]>